E72.539 Billable / specific Primary hyperoxaluria, unspecified
ICD-10-CM E72.539 identifies “Primary hyperoxaluria, unspecified” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
No additional notes.
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E70-E88 · Metabolic disorders (E70-E88)
Excludes 15
Excludes 21
Ehlers-Danlos syndromes (Q79.6-)
E72 · Other disorders of amino-acid metabolism
E72.53 · Primary hyperoxaluria
Inclusion terms2
- Oxalosis
- Oxaluria
Excludes 11
secondary hyperoxaluria (E72.54-)
Official index references
Official index references (1)
Disorder(of) (1)
Official conversion history
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: E72.53
History
Code history
Latest recorded change · FY2026
Effective from
- Added
Primary hyperoxaluria, unspecified
Billable diagnosis code
CDC/NCHS · FY2026All editions (3)
| All editions | Effective from | Code history |
|---|---|---|
| FY2026 | 2025-10-01 | Added |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.